Beta-Thalassemia Completed Phase 2 Trials for Luspatercept (DB12281)

Also known as: Beta-thalassemia / Thalassemia beta / Beta thalassemia / Beta thalassaemia / Beta thalassemia major / Thalassaemia beta / Beta-thalassaemia

IndicationStatusPhase
DBCOND0027982 (Beta-Thalassemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01749540Study to Evaluate the Effects of ACE-536 in Patients With Beta-thalassemiaTreatment